GMP at the right level

When startups and established pharmaceutical companies come together, misleading comparisons often arise. Ambition is rarely the problem. The difference lies in maturity, resources, and structure.

Large companies have had time to establish comprehensive systems, clearly defined roles, and standardized work processes. Smaller companies are often in the midst of building these systems while simultaneously driving innovation, development, and commercialization. Trying to copy large companies’ GMP practices to the letter is neither efficient nor practical.

The right level is not the same as the lowest level

A common misconception is that adapted GMP entails lower standards. In reality, the opposite is true. It is about understanding your actual risks and focusing on what is critical to product quality, data integrity patient safety. A risk-based approach makes it possible to set the right priorities and build quality where it is truly needed.

The concept of “good enough” sometimes raises concerns. But “good enough” doesn’t mean doing too little. It means doing the right amount. Quality in proportion to risk and complexity. A smaller company cannot build everything at once. That is why it is necessary to identify the most critical processes early on and secure them with clear work procedures, simple risk analyses, and well-thought-out documentation. This is often more sustainable than trying to create perfect systems everywhere from the start.

Manual processes require more discipline, not less

In many smaller organizations, manual processes are still a standard part of everyday life. Excel, paper-based documentation, and logbooks are used to track deviations, changes, and traceability. This is perfectly reasonable in the early stages. The challenge arises when the business grows and the volume of data increases.

Manual solutions can work well, but only if they are properly managed. This means version control, restricted access, clearly defined templates, and a shared storage structure. Above all, it requires an understanding of why traceability is crucial. What was changed, by whom, and why. When these questions can no longer be answered with certainty, manual processes quickly become a risk rather than a support.

Digital quality management systems often have traceability built in from the start. But the same principle applies here as well. Technology alone cannot solve cultural issues. Without clear procedures and training, even advanced systems risk being used incorrectly.

Qualification and validation as strategic tools

Qualification and validation are often perceived as extensive and time-consuming, especially in smaller organizations. However, the right approach can save both time and resources. The key is to take a risk-based approach and ensure that the scope of the process reflects its impact on quality and safety.

International guidelines such as GAMP 5 emphasize precisely this point. The scope must be justified and tailored to the system’s complexity and intended use. For standard equipment and off-the-shelf products, the qualification process is often more limited in scope. Complex and integrated systems require more extensive testing.

One often underestimated benefit is collaboration with suppliers. Suppliers possess in-depth knowledge of their systems and can assist with installation validations and functional tests. At the same time, responsibility can never be outsourced. It is always the organization that must ensure that the documentation meets regulatory requirements. Supplier assessments, review of protocols, and an understanding of how changes are managed are therefore crucial.

data integrity a matter of behavior

data integrity often data integrity to an IT issue. In practice, it is just as much a cultural issue. Clear roles, individual logins, and technical safeguards are important, but they are ineffective without the right behaviors. Shared accounts, informal approvals, and unclear responsibilities are common risks in smaller organizations where many people wear multiple hats.

Outsourcing IT to SaaS providers is common and often effective. However, responsibility for data, backups, and availability always remains with the business. Defining responsibilities early on, securing agreements, and understanding how data is protected are central aspects of GMP compliance.

The organizations that are most successful are those that establish a culture early on in which quality is a natural part of everyday life—a culture where people understand why the rules exist and how they contribute to trust, both internally and externally.

GMP as the foundation for long-term success

Regardless of company size, the goal remains the same: reliable product quality, secure data, and patient safety. The path to achieving this varies. Smaller companies often have the advantage of faster decision-making processes and close ties to their operations. By combining this with a risk-based and pragmatic approach to GMP, a strong foundation for scalability is established.

In our experience, companies that dare to be deliberately pragmatic—without compromising on critical standards—are better equipped to handle future growth, partnerships, and inspections. GMP then becomes not a necessary evil, but a strategic asset.

What does your journey look like today? Do you have the right level of structure and control for where you are now and where you want to go? We’d be happy to share our experiences and continue the conversation. Please reach out if you’d like to discuss how GMP can support your specific business.

Listen to the podcast“GMP at the Right Level – How Smaller Companies Build Quality for Growth.”